[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$rhhby

Roche's Giredestrant shows a XX% reduced risk of recurrence or death in Phase X breast cancer trials, potentially offering a new oral alternative to injectables. The company also received EU approval for Gazyvaro in lupus nephritis, signaling advancements in multiple therapeutic areas.

About $rhhby

This topic refers to the decentralized digital currency and its associated blockchain technology.

Insights

• $rhhby posts created is up XXXXX% from the previous week.

Engagements: XXXXX (24h)

Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
X Week: XXXXXX -XX%
X Month: XXXXXXX -XX%
X Months: XXXXXXXXX +43%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXX on 2025-03-12
1-Year Low: XXX on 2025-12-06

Engagements by network (24h): X: XXXXX

Mentions: XX (24h)

Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
X Week: XXX -XXXX%
X Month: XXX -XX%
X Months: XXXXX +130%
X Year: XXXXX +97%
1-Year High: XXX on 2025-08-03
1-Year Low: XX on 2025-01-27

Mentions by network (24h): X: XXX

Creators: XX (24h)

Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $rhhby in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX
X Week: XX -XX%
X Month: XXX -XX%
X Months: XXX -XX%
X Year: XXX +19%
1-Year High: XXX on 2025-03-06
1-Year Low: XX on 2025-09-15

The most influential creators that mention $rhhby in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@Quantumup1	X	XXXXX	X	XXXXX
@yaireinhorn	X	XXXXXX	X	XXX
@BiopharmIQ	X	XXXXXX	X	XXX
@OzmosiHealth	X	XXXXX	X	XXX
@Roche	X	XXXXXXX	X	XX
@bioinvestor24	X	XXXXX	X	XX
@ConnieHillCS	X	XXXXXX	X	XX
@HalevyMike	X	XXXXX	X	XX
@Reignots	X	XXXXX	X	XX

View More

Sentiment: XX%

Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -X%
X Month: XX% -X%
X Months: XX% +12%
X Year: XX% -X%
1-Year High: XXX% on 2025-01-27
1-Year Low: XX% on 2025-08-09

Most Supportive Themes:

• Community Building: (40%) Focus on fostering a strong and engaged community around the topic.
• Educational Content: (30%) Providing valuable information and learning opportunities for the audience.
• Positive Reinforcement: (20%) Highlighting successes and encouraging continued participation.

Most Critical Themes:

• Market Volatility: (60.5%) Significant fluctuations in the market are causing concern among investors.
• Regulatory Uncertainty: (39.5%) Unclear future regulations are creating apprehension and impacting investment decisions.

Top $rhhby Social Posts

Top posts by engagements in the last XX hours

Showing only X posts for non-authenticated requests. Use your API key in requests for full results.

"$RHHBY Hoffmann-La Roche presented P3 Breast Cancer results on 2025-12-10 for Giredestrant More Info:"
X Link @OzmosiHealth 2025-12-11T18:33Z 3018 followers, XXX engagements

"Goldman Sachs $OLMA's PT to $XX from $XX and reiterated at a Buy rating. $RHHBY $NVS PFE AZN LLY ARVN H.C. WainwrightPT to $XX from $XX and reiterated at a Buy rating. Here's what the Analysts had to say:"
X Link @Quantumup1 2025-12-11T12:17Z 3928 followers, 1289 engagements

"📰Roche just dropped blockbuster Phase X data for its oral SERD in early breast cancer: XX% lower risk of recurrence or death vs standard endocrine therapy. First big oral alternative to injectables in decades. $RHHBY $ROG.SW This ones going to move the needle in HR+ breast cancer treatment"
X Link @PDUFA_Pulse 2025-12-10T20:53Z XXX followers, XXX engagements

"$SGMO #chronicpain #nonopioid #Fabry #HemA $LLY $ABBV $AZN $ALPMY $RHHBY $VRTX $PFE MethO made himself an exciting Xmas present added a few thousands more to his stash at these bargain levels and still not stopping here 💎😎🫵🏽"
X Link @MethOSilly 2025-12-10T16:00Z XX followers, XXX engagements